Trademark Overview
On Thursday, December 12, 2024, a trademark application was filed for VISYNC with the United States Patent and Trademark Office. The USPTO has given the VISYNC trademark a serial number of 79423184. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, May 30, 2025. This trademark is owned by VISYNC TECHNOLOGIES, S.A.. The VISYNC trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals, medical and veterinary preparations; biopharmaceuticals, and advanced therapy medicinal products (atmps); medicines for human use that are based on genes, tissues or cells; drugs for medical purposes; pharmaceutical preparations, biopharmaceuticals, and advanced therapy medicinal products (atmps) for systemic or targeted delivery, namely preparations suitable for nasal delivery, nose-to-brain delivery; pharmaceuticals, biopharmaceuticals, and advanced therapy medicinal products (atmps), medical and veterinary preparations, namely preparations comprising biomolecules, cells, viruses, virus-like particles, exosomes, nanoparticles or liposomes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents and kits.
Medical diagnostic services; handling of blood samples; diagnosis of diseases.
Surgical, medical and veterinary apparatus and instruments; medical apparatus and instruments, namely drug delivery devices and diagnostic apparatus for medical purposes; diagnostic, examination and monitoring equipment.
Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; pharmaceutical and biological analysis and research services; research, development and manufacturing activities in the field of medicines, namely biomolecules, cells, viruses, virus-like particles, exosomes, nanoparticles, liposomes and vaccines; research, development and manufacturing activities in the field of delivery of medicines namely, preparations suitable for nasal delivery, nose-to-brain delivery; research and development of manufacturing processes for the pharmaceutical industry; optimization of processes for the pharmaceutical industry; design and development of medical diagnostic apparatus; scientific research for medical purposes in the area of disease.
